BERTRANGE, LU: Amplexor, a content management corporation is planning to incorporate the life sciences brand to specialize in helping life science organizations accelerate their speed in the market and expand in new locations.
The services include technology consultancy, implementation and management services, as well as technical writing, medical translation, linguistic validation services, and creation and management of marketing assets. The life science organization manages content deriving greater value for their investments.
Amplexor is the combination of technology and service powerhouses which includes: Euroscript, Infotehna, Foreign exchange translations and Amplexor. Euroscript is a content management organization, while Infotehna group supports the global life sciences industry by providing comprehensive, flexible content and process management as well as publishing software solutions to deliver added value at reasonable costs. Foreign Exchange translations, provides professional medical translation and Amplexor, a platform for managing content across web, mobile and social channels. The combined group is now rebranded as Amplexor.
Amplexor effectively tackles challenges in research and development, clinical trials, regulatory affairs, pharmacovigilance, quality assurance, quality control and manufacturing. The organization improves operational efficiency and performance by reducing regulatory risks and attaining sustainable compliance.
“Content management in the life sciences industry must transcend individual initiatives such as IDMP [Identification of Medical Products] compliance. Companies need a reliable way to manage not just what’s submitted to regulators, but also what goes out on the packaging, and on their web site, and what’s distributed across digital and social media – in every region and every country,” says Mark Evenepoel, Group CEO, Amplexor.